User menu

Systemic Treatments: Chemotherapy and Targeted Therapies

Bibliographic reference Machiels, Jean-Pascal ; Schmitz, Sandra. Systemic Treatments: Chemotherapy and Targeted Therapies. In: Vermorken, J.B., Budach, V., Leemans, C.R., Machiels, J.-P., Nicolai, P., O'Sullivan, B., Critical Issues in Head and Neck Oncology, Springer  : (Switzerland) Basel 2017, p. 221-232
Permanent URL http://hdl.handle.net/2078.1/185586
  1. Dillon Magnus T., Harrington Kevin J., Human Papillomavirus–Negative Pharyngeal Cancer, 10.1200/jco.2015.60.7804
  2. Nguyen-Tan Phuc Felix, Zhang Qiang, Ang K. Kian, Weber Randal S., Rosenthal David I., Soulieres Denis, Kim Harold, Silverman Craig, Raben Adam, Galloway Thomas J., Fortin André, Gore Elizabeth, Westra William H., Chung Christine H., Jordan Richard C., Gillison Maura L., List Marcie, Le Quynh-Thu, Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity, 10.1200/jco.2014.55.3925
  3. Machiels Jean-Pascal, Lambrecht Maarten, Hanin François-Xavier, Duprez Thierry, Gregoire Vincent, Schmitz Sandra, Hamoir Marc, Advances in the management of squamous cell carcinoma of the head and neck, 10.12703/p6-44
  4. Vermorken Jan B., Mesia Ricard, Rivera Fernando, Remenar Eva, Kawecki Andrzej, Rottey Sylvie, Erfan Jozsef, Zabolotnyy Dmytro, Kienzer Heinz-Roland, Cupissol Didier, Peyrade Frederic, Benasso Marco, Vynnychenko Ihor, De Raucourt Dominique, Bokemeyer Carsten, Schueler Armin, Amellal Nadia, Hitt Ricardo, Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer, 10.1056/nejmoa0802656
  5. Machiels Jean-Pascal, Subramanian Somasundaram, Ruzsa Agnes, Repassy Gabor, Lifirenko Igor, Flygare Annika, Sørensen Per, Nielsen Tina, Lisby Steen, Clement Paul MJ, Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial, 10.1016/s1470-2045(11)70034-1
  6. Argiris Athanassios, Li Yi, Forastiere Arlene, Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck : An analysis of two Eastern Cooperative Oncology Group randomized trials, 10.1002/cncr.20640
  7. Ang K. Kian, Harris Jonathan, Wheeler Richard, Weber Randal, Rosenthal David I., Nguyen-Tân Phuc Felix, Westra William H., Chung Christine H., Jordan Richard C., Lu Charles, Kim Harold, Axelrod Rita, Silverman C. Craig, Redmond Kevin P., Gillison Maura L., Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer, 10.1056/nejmoa0912217
  8. Fakhry Carole, Zhang Qiang, Nguyen-Tan Phuc Felix, Rosenthal David, El-Naggar Adel, Garden Adam S., Soulieres Denis, Trotti Andy, Avizonis Vilija, Ridge John Andrew, Harris Jonathan, Le Quynh-Thu, Gillison Maura, Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma, 10.1200/jco.2014.55.1937
  9. Argiris A., Li S., Ghebremichael M., Egloff A. M., Wang L., Forastiere A. A., Burtness B., Mehra R., Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials, 10.1093/annonc/mdu167
  10. Gibson Michael K., Li Yi, Murphy Barbara, Hussain Maha H.A., DeConti Ronald C., Ensley John, Forastiere Arlene A., Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group, 10.1200/jco.2005.01.057
  11. Forastiere A A, Metch B, Schuller D E, Ensley J F, Hutchins L F, Triozzi P, Kish J A, McClure S, VonFeldt E, Williamson S K, Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study., 10.1200/jco.1992.10.8.1245
  12. Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol. 1994;21:311–9.
  13. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck : The Liverpool Head and Neck Oncology Group, 10.1038/bjc.1990.59
  14. Morton R.P., Rugman F., Dorman E.B., Stoney P.J., Wilson J.A., McCormick M., Veevers A., Stell P.M., Cisplatinum and Bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial, 10.1007/bf00263902
  15. Campbell JB, Dorman EB, McCormick M, et al. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer. Acta Otolaryngol. 1987;103:519–28.
  16. Colevas A. Dimitrios, Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck, 10.1200/jco.2005.05.3348
  17. Sacco Assuntina G., Cohen Ezra E., Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma, 10.1200/jco.2015.62.0963
  18. Machiels Jean-Pascal H, Haddad Robert I, Fayette Jérôme, Licitra Lisa F, Tahara Makoto, Vermorken Jan B, Clement Paul M, Gauler Thomas, Cupissol Didier, Grau Juan José, Guigay Joël, Caponigro Francesco, de Castro Gilberto, de Souza Viana Luciano, Keilholz Ulrich, del Campo Joseph M, Cong Xiuyu Julie, Ehrnrooth Eva, Cohen Ezra E W, Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial, 10.1016/s1470-2045(15)70124-5
  19. Woods R L, Fox R M, Tattersall M H, Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation., 10.1136/bmj.282.6264.600
  20. Stewart J. Simon W., Cohen Ezra E.W., Licitra Lisa, Van Herpen Carla M.L., Khorprasert Chonlakiet, Soulieres Denis, Vodvarka Pavel, Rischin Danny, Garin Avgust M., Hirsch Fred R., Varella-Garcia Marileila, Ghiorghiu Serban, Hargreaves Laura, Armour Alison, Speake Georgina, Swaisland Alan, Vokes Everett E., Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck, 10.1200/jco.2008.17.0530
  21. Dreyfuss A I, Clark J R, Norris C M, Rossi R M, Lucarini J W, Busse P M, Poulin M D, Thornhill L, Costello R, Posner M R, Docetaxel: an active drug for squamous cell carcinoma of the head and neck., 10.1200/jco.1996.14.5.1672
  22. Forastiere Arlene A., Shank Darleen, Neuberg Donna, Taylor Samuel G., DeConti Ronald C., Adams George, Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390), 10.1002/(sici)1097-0142(19980601)82:11<2270::aid-cncr24>3.0.co;2-q
  23. Fayette Jérôme, Montella Anthony, Chabaud Sylvie, Bachelot Thomas, Pommier Pascal, Girodet Didier, Racadot Séverine, Montbarbon Xavier, Favier Bertrand, Zrounba Philippe, Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution : , 10.1097/cad.0b013e3283388e60
  24. Langer Corey J., Li Yi, Jennings Timothy, DeConti Ronald C., Nair Suresh, Cohen Roger B., Forastiere Arlene A., Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): A Trial of the Eastern Cooperative Oncology Group, 10.1081/cnv-200039628
  25. Clavel M., Vermorken J. B., Cognetti F., Cappelaere P., Mulder P. H. M.de, Schornagel J. H., Tueni E. A., Verweij J., Wildiers J., Clerico M., Dalesio O., Kirkpatrick A., Snow G. B., Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck, 10.1093/oxfordjournals.annonc.a058906
  26. Jacobs C, Lyman G, Velez-García E, Sridhar K S, Knight W, Hochster H, Goodnough L T, Mortimer J E, Einhorn L H, Schacter L, A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck., 10.1200/jco.1992.10.2.257
  27. Urba Susan, van Herpen Carla M. L., Sahoo Tarini Prasad, Shin Dong M., Licitra Lisa, Mezei Klara, Reuter Christoph, Hitt Ricardo, Russo Francesca, Chang Shao-Chun, Hossain Anwar M., Frimodt-Moller Bente, Koustenis Andrew, Hong Ruey-Long, Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer : Final results of a randomized, double-blind, placebo-controlled, phase 3 study, 10.1002/cncr.27449
  28. Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002;62:7350–6.
  29. Vermorken Jan. B., Herbst Roy S., Leon Xavier, Amellal Nadia, Baselga Jose, Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies, 10.1002/cncr.23442
  30. Hitt R., Irigoyen A., Cortes-Funes H., Grau J. J., García-Sáenz J. A., Cruz-Hernandez J. J., Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck, 10.1093/annonc/mdr367
  31. Vermorken Jan B, Stöhlmacher-Williams Jan, Davidenko Irina, Licitra Lisa, Winquist Eric, Villanueva Cristian, Foa Paolo, Rottey Sylvie, Skladowski Krzysztof, Tahara Makoto, Pai Vasant R, Faivre Sandrine, Blajman Cesar R, Forastiere Arlene A, Stein Brian N, Oliner Kelly S, Pan Zhiying, Bach Bruce A, Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial, 10.1016/s1470-2045(13)70181-5
  32. Argiris Athanassios, Ghebremichael Musie, Gilbert Jill, Lee Ju-Whei, Sachidanandam Kamakshi, Kolesar Jill M., Burtness Barbara, Forastiere Arlene A., Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial, 10.1200/jco.2012.45.4272
  33. Abdul Razak A. R., Soulieres D., Laurie S. A., Hotte S. J., Singh S., Winquist E., Chia S., Le Tourneau C., Nguyen-Tan P.- F., Chen E. X., Chan K. K., Wang T., Giri N., Mormont C., Quinn S., Siu L. L., A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck, 10.1093/annonc/mds503
  34. Schaefer Gabriele, Haber Lauric, Crocker Lisa M., Shia Steven, Shao Lily, Dowbenko Donald, Totpal Klara, Wong Anne, Lee Chingwei V., Stawicki Scott, Clark Robyn, Fields Carter, Lewis Phillips Gail D., Prell Rodney A., Danilenko Dimitry M., Franke Yvonne, Stephan Jean-Philippe, Hwang Jiyoung, Wu Yan, Bostrom Jenny, Sliwkowski Mark X., Fuh Germaine, Eigenbrot Charles, A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies, 10.1016/j.ccr.2011.09.003
  35. Juric D., Dienstmann R., Cervantes A., Hidalgo M., Messersmith W., Blumenschein G. R., Tabernero J., Roda D., Calles A., Jimeno A., Wang X., Bohorquez S. S., Leddy C., Littman C., Kapp A. V., Shames D. S., Penuel E., Amler L. C., Pirzkall A., Baselga J., Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors, 10.1158/1078-0432.ccr-14-2412
  36. Fayette J., Wirth L.J., Oprean C., Hitt R., Udrea A., Jimeno A., Rischin D., Nutting C., Harari P., Cso˝szi T., Cernea D., Wang X., Kapp A., Anderson M., Penuel E., McCall B., Pirzkall A., Vermorken J.B., 986ORANDOMIZED PHASE II STUDY OF MEHD7945A (MEHD) VS CETUXIMAB (CET) IN >= 2ND-LINE RECURRENT/METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD & NECK (RMSCCHN) PROGRESSIVE ON/AFTER PLATINUM-BASED CHEMOTHERAPY (PTCT), 10.1093/annonc/mdu340.1
  37. Vermorken J. B., Psyrri A., Mesía R., Peyrade F., Beier F., de Blas B., Celik I., Licitra L., Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial, 10.1093/annonc/mdt574
  38. Cohen E, Licitra L, Fayette J et al. Biomarker analysis in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients (pts) treated with second-line afatinib versus methotrexate (MTX): LUX-Head & Neck 1 (LUX-H&N1). J Clin Oncol. 2015;33, abstract N°6023.
  39. Lawrence Michael S., Sougnez Carrie, Lichtenstein Lee, Cibulskis Kristian, Lander Eric, Gabriel Stacey B., Getz Gad, Ally Adrian, Balasundaram Miruna, Birol Inanc, Bowlby Reanne, Brooks Denise, Butterfield Yaron S. N., Carlsen Rebecca, Cheng Dean, Chu Andy, Dhalla Noreen, Guin Ranabir, Holt Robert A., Jones Steven J. M., Lee Darlene, Li Haiyan I., Marra Marco A., Mayo Michael, Moore Richard A., Mungall Andrew J., Gordon Robertson A., Schein Jacqueline E., Sipahimalani Payal, Tam Angela, Thiessen Nina, Wong Tina, Protopopov Alexei, Santoso Netty, Lee Semin, Parfenov Michael, Zhang Jianhua, Mahadeshwar Harshad S., Tang Jiabin, Ren Xiaojia, Seth Sahil, Haseley Psalm, Zeng Dong, Yang Lixing, Xu Andrew W., Song Xingzhi, Pantazi Angeliki, Bristow Christopher A., Hadjipanayis Angela, Seidman Jonathan, Chin Lynda, Park Peter J., Kucherlapati Raju, Akbani Rehan, Casasent Tod, Liu Wenbin, Lu Yiling, Mills Gordon, Motter Thomas, Weinstein John, Diao Lixia, Wang Jing, Hong Fan You, Liu Jinze, Wang Kai, Todd Auman J., Balu Saianand, Bodenheimer Thomas, Buda Elizabeth, Neil Hayes D., Hoadley Katherine A., Hoyle Alan P., Jefferys Stuart R., Jones Corbin D., Kimes Patrick K., Liu Yufeng, Marron J. S., Meng Shaowu, Mieczkowski Piotr A., Mose Lisle E., Parker Joel S., Perou Charles M., Prins Jan F., Roach Jeffrey, Shi Yan, Simons Janae V., Singh Darshan, Soloway Matthew G., Tan Donghui, Veluvolu Umadevi, Walter Vonn, Waring Scot, Wilkerson Matthew D., Wu Junyuan, Zhao Ni, Cherniack Andrew D., Hammerman Peter S., Tward Aaron D., Sekhar Pedamallu Chandra, Saksena Gordon, Jung Joonil, Ojesina Akinyemi I., Carter Scott L., Zack Travis I., Schumacher Steven E., Beroukhim Rameen, Freeman Samuel S., Meyerson Matthew, Cho Juok, Chin Lynda, Getz Gad, Noble Michael S., DiCara Daniel, Zhang Hailei, Heiman David I., Gehlenborg Nils, Voet Doug, Lin Pei, Frazer Scott, Stojanov Petar, Liu Yingchun, Zou Lihua, Kim Jaegil, Sougnez Carrie, Gabriel Stacey B., Lawrence Michael S., Muzny Donna, Doddapaneni HarshaVardhan, Kovar Christie, Reid Jeff, Morton Donna, Han Yi, Hale Walker, Chao Hsu, Chang Kyle, Drummond Jennifer A., Gibbs Richard A., Kakkar Nipun, Wheeler David, Xi Liu, Ciriello Giovanni, Ladanyi Marc, Lee William, Ramirez Ricardo, Sander Chris, Shen Ronglai, Sinha Rileen, Weinhold Nils, Taylor Barry S., Arman Aksoy B., Dresdner Gideon, Gao Jianjiong, Gross Benjamin, Jacobsen Anders, Reva Boris, Schultz Nikolaus, Onur Sumer S., Sun Yichao, Chan Timothy A., Morris Luc G., Stuart Joshua, Benz Stephen, Ng Sam, Benz Christopher, Yau Christina, Baylin Stephen B., Cope Leslie, Danilova Ludmila, Herman James G., Bootwalla Moiz, Maglinte Dennis T., Laird Peter W., Triche Timothy, Weisenberger Daniel J., Van Den Berg David J., Agrawal Nishant, Bishop Justin, Boutros Paul C., Bruce Jeff P., Averett Byers Lauren, Califano Joseph, Carey Thomas E., Chen Zhong, Cheng Hui, Chiosea Simion I., Cohen Ezra, Diergaarde Brenda, Marie Egloff Ann, El-Naggar Adel K., Ferris Robert L., Frederick Mitchell J., Grandis Jennifer R., Guo Yan, Haddad Robert I., Hammerman Peter S., Harris Thomas, Neil Hayes D., Hui Angela B. Y., Jack Lee J., Lippman Scott M., Liu Fei-Fei, McHugh Jonathan B., Myers Jeff, Kwok Shing Ng Patrick, Perez-Ordonez Bayardo, Pickering Curtis R., Prystowsky Michael, Romkes Marjorie, Saleh Anthony D., Sartor Maureen A., Seethala Raja, Seiwert Tanguy Y., Si Han, Tward Aaron D., Van Waes Carter, Waggott Daryl M., Wiznerowicz Maciej, Yarbrough Wendell G., Zhang Jiexin, Zuo Zhixiang, Burnett Ken, Crain Daniel, Gardner Johanna, Lau Kevin, Mallery David, Morris Scott, Paulauskis Joseph, Penny Robert, Shelton Candace, Shelton Troy, Sherman Mark, Yena Peggy, Black Aaron D., Bowen Jay, Frick Jessica, Gastier-Foster Julie M., Harper Hollie A., Leraas Kristen, Lichtenberg Tara M., Ramirez Nilsa C., Wise Lisa, Zmuda Erik, Baboud Julien, Jensen Mark A., Kahn Ari B., Pihl Todd D., Pot David A., Srinivasan Deepak, Walton Jessica S., Wan Yunhu, Burton Robert A., Davidsen Tanja, Demchok John A., Eley Greg, Ferguson Martin L., Mills Shaw Kenna R., Ozenberger Bradley A., Sheth Margi, Sofia Heidi J., Tarnuzzer Roy, Wang Zhining, Yang Liming, Claude Zenklusen Jean, Saller Charles, Tarvin Katherine, Chen Chu, Bollag Roni, Weinberger Paul, Golusiński Wojciech, Golusiński Paweł, Ibbs Matthew, Korski Konstanty, Mackiewicz Andrzej, Suchorska Wiktoria, Szybiak Bartosz, Wiznerowicz Maciej, Burnett Ken, Curley Erin, Gardner Johanna, Mallery David, Penny Robert, Shelton Troy, Yena Peggy, Beard Christina, Mitchell Colleen, Sandusky George, Agrawal Nishant, Ahn Julie, Bishop Justin, Califano Joseph, Khan Zubair, Bruce Jeff P., Hui Angela B. Y., Irish Jonathan, Liu Fei-Fei, Perez-Ordonez Bayardo, Waldron John, Boutros Paul C., Waggott Daryl M., Myers Jeff, William William N., Lippman Scott M., Egea Sophie, Gomez-Fernandez Carmen, Herbert Lynn, Bradford Carol R., Carey Thomas E., Chepeha Douglas B., Haddad Andrea S., Jones Tamara R., Komarck Christine M., Malakh Mayya, McHugh Jonathan B., Moyer Jeffrey S., Nguyen Ariane, Peterson Lisa A., Prince Mark E., Rozek Laura S., Sartor Maureen A., Taylor Evan G., Walline Heather M., Wolf Gregory T., Boice Lori, Chera Bhishamjit S., Funkhouser William K., Gulley Margaret L., Hackman Trevor G., Neil Hayes D., Hayward Michele C., Huang Mei, Kimryn Rathmell W., Salazar Ashley H., Shockley William W., Shores Carol G., Thorne Leigh, Weissler Mark C., Wrenn Sylvia, Zanation Adam M., Chiosea Simion I., Diergaarde Brenda, Marie Egloff Ann, Ferris Robert L., Romkes Marjorie, Seethala Raja, Brown Brandee T., Guo Yan, Pham Michelle, Yarbrough Wendell G., Comprehensive genomic characterization of head and neck squamous cell carcinomas, 10.1038/nature14129
  40. Schmitz Sandra, Ang Kie Kian, Vermorken Jan, Haddad Robert, Suarez Carlos, Wolf Gregory T., Hamoir Marc, Machiels Jean-Pascal, Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions, 10.1016/j.ctrv.2013.09.007
  41. Andre F., Mardis E., Salm M., Soria J.- C., Siu L. L., Swanton C., Prioritizing targets for precision cancer medicine, 10.1093/annonc/mdu478